THALES
18.5.2021 15:02:08 CEST | Business Wire | Press release
Thales today announced new data protection solutions for Google Cloud, Microsoft Azure, and Amazon Web Services, solidifying its role as a trusted third party for multicloud data security.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210518005282/en/
With each cloud provider having unique data protection mechanisms and key management offerings, multicloud data protection presents a complex security challenge for organisations. Thales’ latest cloud data security solutions allow customers to maintain control of and manage their encryption keys, as well as manage access and authentication across hybrid and multicloud environments.
“These capabilities are critical to cloud migration and security, especially with such accelerated growth in this area,” said Sunil Potti, Vice President and General Manager of Google Cloud Security . “True to our mission, we have forged this collaboration with Thales to further protect our customer’s most sensitive information. We are empowering customers to leverage the full potential of Google Cloud technology for sensitive workloads, by utilising the Customer-Managed Encryption Key-integrated GCP services, CipherTrust Cloud Key Manager and SafeNet Trusted Access for access management and authentication from Thales. This will enable enterprises to deal with a fluid and dynamic business environment where protecting sensitive data in the cloud is of extreme importance.”
Simplifying Multicloud Security
As customers look to reap the rewards from multicloud environments, Thales is making it easier to ensure protection against reputational risk and financial penalties arising from a cloud data breach. As such, customers will benefit from enhanced capabilities to Discover, Protect and Control sensitive data across multicloud environments, including the ability to:
Discover Sensitive Data in the Cloud and On-Premises
Thales Data Discovery and Classification automates the discovery, classification and protection of data in the cloud and on-premises using automation policies that identify sensitive data and protect the data with encryption or tokenisation. These capabilities have now been extended to the discovery and classification of data in Amazon Web Services S3 buckets and Azure Blob storage.
Protect Sensitive Data and Workloads in the Cloud
To address both the complexity of where data is stored and to help ensure data sovereignty in a multicloud environment, effective encryption and tokenisation is needed. Specific new data protection capabilities for cloud platforms include:
- CipherTrust Transparent Encryption for advanced encryption and access controls, protects data in Amazon Web Services Simple Storage Service (S3)
- Encryption of Kubernetes secrets and Google Anthos Service Mesh signing keys
Control Access to Applications and Sensitive Data in the Cloud
The accelerated adoption of encryption has led to the need to manage a far larger number of encryption keys across both traditional data stores and multicloud environments. Thales has enabled new capabilities that allow organisations to control access to data and ownership of their encryption keys, including:
- Thales is also offering CipherTrust Cloud Key Manager support for Google Cloud’s External Key Manager (EKM), building on the existing CipherTrust Key Broker for Google Cloud EKM which is part of the Thales Data Protection on Demand cloud-based platform.
Secure and Protect access at the Login Point
Compromised identities pose one of the greatest risks for data breaches:
- SafeNet Trusted Access integrates out of the box with Google Workspace, Azure and AWS, enforcing the appropriate access controls and authentication for privileged and regular users.
- SafeNet Trusted Access is offering new abilities to provide authentication and authorisation for APIs and for applications not using industry-standard protocols such as SAML and OIDC.
“The proliferation of multicloud computing has created new organizational challenges in managing data across many different cloud environments. Whilst organisations have benefited from scalability and speed to market thanks to the power of cloud, the ever expanding IT cloud landscape has added greater complexity to data management and security,” said Sébastien Cano, Senior Vice President, Cloud Protection and Licensing activities at Thales . “In a post pandemic, highly regulated world, it is even more important for organisations to understand what data they have, where it sits, who can access it and the risks associated with managing it. Only once an organization understands all of these data lifecycle aspects, can they ensure that it is secured and managed correctly.”
Additional Resources
Thales and Google Cloud have forged a strong collaboration to help enterprises migrate sensitive data between public cloud, hybrid and private IT infrastructures. Watch this video with Sunil Potti, VP and GM at Google Cloud Security to learn more.
About Thales
Thales (Euronext Paris: HO) is a global leader in advanced technologies, investing in digital and “deep tech” innovations – connectivity, big data, artificial intelligence, cybersecurity and quantum computing – to build a confident future crucial for the development of our societies. The Group provides its customers – businesses, organisations and governments – in the defense, aeronautics, space, transport, and digital identity and security domains with solutions, services and products that help them fulfil their critical role, consideration for the individual being the driving force behind all decisions.
Thales has 81,000 employees in 68 countries. In 2020 the Group generated sales of €17 billion.
Thales Group
Security
View source version on businesswire.com: https://www.businesswire.com/news/home/20210518005282/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom